Virulence Factors of E. coli ST131 and Its H30 and H30Rx Subclones Among Extended-Spectrum Beta-Lactamase Producing Isolates
International Journal of Genetics and Genomics
Volume 4, Issue 4, August 2016, Pages: 36-39
Received: Aug. 17, 2016; Accepted: Aug. 26, 2016; Published: Sep. 18, 2016
Views 3998      Downloads 186
Authors
Khadega Yahya Abdullah AL-hetar, Department of Studies in Microbiology, University of Mysore, Mysore, Karnataka, India
Nanjaiah Lakshmidevi, Department of Studies in Microbiology, University of Mysore, Mysore, Karnataka, India
Article Tools
Follow on us
Abstract
Escherichia coli sequence type 131 (ST131) is a pandemic clone causing predominantly community and hospital-onset antimicrobial-resistant infections. Recently, H30-Rx subclone of E. coli has been disseminated among ST131 strains in combination with beta lactamase subtype CTX-15that may play a role in the prevalence of antibiotic resistance among E. coli strains that cause extra-intestinal infections. This study has been done to investigate the virulence factors of ST131 with their subclones: H30-Rx and non H30-Rx strains. A hundred E. coli isolates which were isolated from different clinical samples were collected from K.R hospital, Mysore. Polymerase chain reaction (PCR) method was used to investigate 19 of the virulence factors among E. coli stains. Out of 100 E. coli strains, 87 of the isolates belonged to ST131, 24 isolates belonged to H30 subclone, and 22/24 (91.7%) belonged to H30-Rx subcolne. ST131 strains harbored high virulence factors more than non ST131 strains and the differences between them were significant for papC, papEF and fyuA genes. All H30-Rx strains were positive for iutA and fimH, however, 95.5% and 81.8% of H30-Rx strains were positive for fyuA and kpsMII respectively and the differences between H30-Rx and non H30-Rx strains were significant for those genes. There are no more reports about H30 and H30-Rx subclones of ST131 E. coli in India. Further studies should be done to investigate the prevalence of ST131 in different places in India and to highlight the other virulence factors to control the dissemination of ST131 clone.
Keywords
E. coli, ESBL, H30 and H30Rx Subclones, ST131, Virulence Factors
To cite this article
Khadega Yahya Abdullah AL-hetar, Nanjaiah Lakshmidevi, Virulence Factors of E. coli ST131 and Its H30 and H30Rx Subclones Among Extended-Spectrum Beta-Lactamase Producing Isolates, International Journal of Genetics and Genomics. Vol. 4, No. 4, 2016, pp. 36-39. doi: 10.11648/j.ijgg.20160404.12
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Johnson JR, Johnston B, Clabots C, Kuskowski M, Pendyala S, DebRoy C, et al (2010-a). Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob. Agents. Chemother. 54: 546–50. Doi: 10.1128/AAC.01089-09.
[2]
Vigil K, Johnson J, Johnston B, Kontoyiannis D, Mulanovich V, Raad I, et al (2010). Escherichia coli Pyomyositis: An Emerging Infectious Disease among Patients with Hematologic Malignancies. Clin. Infec. Dis. 50: 374–80. Doi: 10.1086/649866.
[3]
Assimacopoulos A, Johnston B, Clabots C, Johnson J (2012). “Post-Prostate Biopsy Infection with Escherichia coli ST131 Leading to Epididymo-Orchitis and Meningitis Caused by Gram-Negative Bacilli”. J. Clin. Microbiol. 50 (12): 4157–4159. Doi: 10.1128/JCM.02026-12.
[4]
Rogers B, Sidjabat H, Paterson D (2011). “Escherichia coli O25b-ST131: a pandemic, multiresistant, communityassociated strain”. J Antimicrob Chemother 66: 1–14. Doi: 10.1093/jac/dkq415.
[5]
Karim A, Poirel L, Nagarajan S, Nordmann P (2001). “Plasmid-Mediated Extended-Spectrum β-Lactmase (CTX-M-3 like) from India and gene association with insersion Sequence ISEcp1”. FEMS Microbiology Letters 201: 237-241.
[6]
Johnson J, Tchesnokova V, Johnston B, Clabots C, Roberts P, Billig M, et al. (2013). A brupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207: 919–928. DOI: 10.1093/ infdis/ jis933.
[7]
Price L, Johnson J, Aziz M, Clabots C, Johnston B, Tchesnokova V, et al. (2013). The Epidemic of Extended-Spectrum-_-Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx. MBio. 4 (6): 1-10. Doi: 10.1128/mBio.00377-13.
[8]
Banerjee R, Robicsek A, Kuskowski M, Porter S, Johnston B, Sokurenko E, et al. (2013-a). Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010. Antimicrob. Agents Chemother. 57 (12): 6385–6388. Doi: 10.1128/AAC.01604-13.
[9]
Johnson J, Johnston B, Clabots C, Kuskowski M, Castanheira M (2010-b). Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States. Clinic. Infect. Dis. 51 (3): 286–294. DOI: 10.1086/653932.
[10]
Alhetar K, Lakshmidevi N (2015). Prevalence of CTX-M-15 -Lactamase Producing Escherichia coliamong Extra-intestinal Infections. Int. J. Curr. Microbiol. App. Sci. 4 (5): 243-250.
[11]
Al-hetar K, Lakshmidevi N (2016-a). Prevalence of H30 and H30-Rx subclones of Escherichia coli Sequence Type (ST131) among Extra-intestinal Clinical Samples. Int. J. Advanc. Sci. Eng. Technol. 61-64.
[12]
Al-hetar K, LakshmideviN (2016-b). Prevalence of Escherichia coli sequence type 131 (ST131) among extra-intestinal clinical isolates in different phylogenetic groups. Int. J. Med. Res. Health. Sci. 5 (3): 90-94.
[13]
Ruppe E, Hem S, Lath S, Gautier V, Ariey F, Sarthou JL, et al. (2009). CTX-M β-lactamases in Escherichia coli from community-acquired urinary tract infectons, Cambodia. Emerg. Infect. Dis. 15: 741-748. Doi: 10.3201/eid1505.071299.
[14]
Johnson J, Stell A (2000). Extended Virulence Genotypes of Escherichia coli Strains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise. J. Infect. Dis. 181: 261–72.
[15]
Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim S, et al. (2010). Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infection; 60: 146–53.
[16]
Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko E, Johnson J. (2013-b). The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates Vary According to Patient Characteristics. Antimicrob. Agents Ch; 57 (12): 5912–5917.
[17]
Reyna-Flores F, Barrios H, Garza-Ramos U, Sánchez-Pérez A, Rojas-Moreno T, Uribe-Salas F, et al. (2013). Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico. Diagn Micr Infec Dis; 76: 396–398.
[18]
Ho P, Chu Y, Lo W, Chow K, Law P, Tse C, et al. (2015). High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients. J. Med Microbiol; 64: 243-247. Doi: 10.1099/jmm.0.000012.
[19]
Merino I, Shaw E, Horcajada J, Cercenado E, Mirelis B, Pallarés A, et al. (2016). CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. J. Antimicrob Chemother; 71 (8): 2125-2130. Doi: 10.1093/jac/dkw133.
[20]
Dahbi G, Mora A, Lópeza C, Alonso M, Mamania R, Marzoaa J, et al. (2013). Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. Int. J. Antimicrob. Ag. 42: 347–351. Doi.org/10.1016/j.ijantimicag.2013.06.017.
[21]
Peirano G, Bij K, Gregson D, and Pitout P. (2012). Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum _-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region. J Clin Microbiol; 294–299.
[22]
Lavigne J, Vergunst A, Goret L, Sotto A, Combescure C, Blanco J, et al. (2012). Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131. PLoS ONE 7 (3): 1-10. Doi: 10.1371/journal.pone.0034294.
[23]
Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, et al. (2013). Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans. Clinic. Infect. Dis. 57 (9): 1256–65. DOI: 10.1093/cid/cit503.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186